Salta al contenuto
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Lingua
Tutti i Campi
Titolo
Autore
Soggetto
Collocazione
ISBN/ISSN
Tag
Cerca
Avanzata
Ranibizumab versus Bevacizuma...
Citazione
Invia SMS
Invia email
Stampa
Esporta il record
Esporta a RefWorks
Esporta a EndNoteWeb
Esporta a EndNote
PLink permanente
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Dettagli Bibliografici
Autori principali:
Chakravarthy, U
,
Harding, S
,
Rogers, C
,
Downes, S
,
Lotery, A
,
Wordsworth, S
,
Reeves, B
Natura:
Journal article
Pubblicazione:
2012
Posseduto
Descrizione
Documenti analoghi
MARC21
Descrizione
Riassunto:
Documenti analoghi
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
di: Chakravarthy, U, et al.
Pubblicazione: (2012)
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: One-year findings from the IVAN randomized trial
di: Chakravarthy, U, et al.
Pubblicazione: (2012)
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial.
di: Dakin, H, et al.
Pubblicazione: (2014)
Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab.
di: Sivaprasad, S, et al.
Pubblicazione: (2011)
Treat-And-extend bevacizumab for neovascular age-related macular degeneration: The importance of baseline characteristics
di: Rush, R, et al.
Pubblicazione: (2014)